“…A number of compounds with diverse chemical structures and mechanisms of action have been explored as MRCs, including thiols (Grdina et al, 2002), cytokines (Waddick et al, 1991;Singh and Yadav, 2005), steroids (Whitnall et al, 2001), antioxidants (Weiss and Landauer, 2000), and nutraceuticals (Srinivasan and Weiss, 1992;Weiss and Landauer, 2000); however, to date none have been approved by the FDA as an MRC against ARS (Mettler and Voelz, 2002). To identify novel countermeasures against radiation and other tissue-damaging stresses, we looked toward the modulation of nuclear factor -B (NF-B), a transcriptional activator of multiple genes encoding: 1) antiapoptotic proteins (for review, see Karin and Lin, 2002), 2) cytokines and growth factors that induce proliferation and survival of HP and other stem cells (Hayden et al, 2006), and 3) reactive oxygen species-scavenging antioxidants (Xu et al, 1999).…”